S X Skapek
Overview
Explore the profile of S X Skapek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
919
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Skapek S, Rhee J, Spicer D, Lassar A
Science
. 1995 Feb;
267(5200):1022-4.
PMID: 7863328
Although the myogenic regulator MyoD is expressed in proliferating myoblasts, differentiation of these cells is limited to the G0 phase of the cell cycle. Forced expression of cyclin D1, but...
12.
Halevy O, Novitch B, Spicer D, Skapek S, Rhee J, Hannon G, et al.
Science
. 1995 Feb;
267(5200):1018-21.
PMID: 7863327
Skeletal muscle differentiation entails the coordination of muscle-specific gene expression and terminal withdrawal from the cell cycle. This cell cycle arrest in the G0 phase requires the retinoblastoma tumor suppressor...
13.
Lassar A, Skapek S, Novitch B
Curr Opin Cell Biol
. 1994 Dec;
6(6):788-94.
PMID: 7880524
Skeletal muscle differentiation entails the coupling of muscle-specific gene expression to terminal withdrawal from the cell cycle. Several models have recently been proposed which attempt to explain how regulated expression...
14.
Skapek S, Jones W, Hoffman K, Kuskie M
Pediatr Infect Dis J
. 1992 May;
11(5):411-3.
PMID: 1630865
No abstract available.
15.
Skapek S, VanDellen A, McMahon D, Postels D, Griffith O, Bigner D, et al.
Cancer Chemother Pharmacol
. 1991 Jan;
28(1):15-21.
PMID: 2040029
Melphalan-induced toxicity in nude mice following pretreatment with a regimen of L-buthionine sulfoximine (BSO), previously shown to enhance the activity of this alkylating agent against rhabdomyosarcoma and glioma xenografts, was...
16.
He X, Skapek S, Wikstrand C, Friedman H, Trojanowski J, Kemshead J, et al.
J Neuropathol Exp Neurol
. 1989 Jan;
48(1):48-68.
PMID: 2535715
An extensive panel of monoclonal antibodies (MAb) and monospecific antisera reactive against neuroectodermal-, neuronal-, glial-, and lymphoid-associated antigens, extracellular matrix, HLA, and cell-surface receptors was used to characterize the phenotype...
17.
Skapek S, COLVIN O, Griffith O, Groothuis D, Colapinto E, Lee Y, et al.
Biochem Pharmacol
. 1988 Nov;
37(22):4313-7.
PMID: 3196356
D-54 MG, a human glioma-derived continuous cell line growing as subcutaneous or intracranial xenografts in athymic mice, was found to be sensitive to the effects of D,L-buthionine-(SR)-sulfoximine, a selective inhibitor...
18.
Friedman H, Skapek S, COLVIN O, ELION G, Blum M, Savina P, et al.
Cancer Res
. 1988 Oct;
48(19):5397-402.
PMID: 3416297
Melphalan transport, glutathione levels, and glutathione-S-transferase activity were measured in two continuous human medulloblastoma cell lines and transplantable xenografts in athymic nude mice, TE-671 and Daoy. In vitro mean glutathione...
19.
Friedman H, COLVIN O, Skapek S, Ludeman S, ELION G, Schold Jr S, et al.
Cancer Res
. 1988 Aug;
48(15):4189-95.
PMID: 3390813
A series of bifunctional alkylators were tested against the genotypically and phenotypically heterogeneous continuous human medulloblastoma cell lines, TE-671, Daoy, and D283 Med in vitro and against TE-671 and Daoy...
20.
Skapek S, COLVIN O, Griffith O, ELION G, Bigner D, Friedman H
Cancer Res
. 1988 May;
48(10):2764-7.
PMID: 3359437
The effect and therapeutic consequences of buthionine-(SR)-sulfoximine (BSO)-mediated depletion of glutathione in the human medulloblastoma-derived cell line, TE-671, growing as s.c. xenografts in athymic nude mice were examined. The glutathione...